Keyphrases
Alternative Pathway
14%
Anti-fibrosis
14%
Antifibrogenic
14%
Antifibrogenic Effect
14%
Apoptosis
14%
Cell Viability
14%
Collagen I
14%
Cytokine Levels
14%
Decreased Expression
14%
Design Approach
14%
DNA Binding
28%
Dose Effect
14%
Double Effect
14%
ELISA Assay
14%
Expression Level
14%
Extracellular Matrix Deposition
14%
Extracellular Proteins
14%
Fibrogenesis
100%
Fibronectin
14%
Fragment Based Drug Design
14%
Hepatic Fibrosis
14%
Hepatic Stellate Cell Activation
100%
Hepatic Stellate cells-T6
14%
Immunofluorescence Assay
14%
In Vivo Experimentation
14%
Inflammatory Cytokines
14%
Inflammatory Stimuli
14%
Inhibitory Proteins
14%
Laminin
14%
LPS-induced Inflammation
14%
LX-2
14%
LX-2 Cells
14%
NF-B
100%
Nuclear DNA (nDNA)
14%
Nuclear factor-κB
14%
Orally Bioavailable
14%
P65 nuclear Translocation
14%
Pathway Activation
14%
Phosphorylation
42%
Propidium Iodide
14%
Serine Residues
14%
Sigma Phase
14%
Signal Transducer and Activator of Transcription 3
100%
Signal Transduction Pathway
14%
Small Molecule Inhibitors
14%
Western Blot Assay
14%
Wound Healing Response
14%
YO-PRO-1
14%
Biochemistry, Genetics and Molecular Biology
Cell Activation
28%
Cell Cycle
14%
Cell Viability
14%
DNA Binding
28%
Fibrogenesis
100%
Fibronectin
14%
Hepatic Stellate Cell
100%
Immunofluorescence
14%
Inflammatory Cytokine
14%
Laminin
14%
Nuclear Factor Kappa B
14%
Propidium Iodide
14%
S Phase
14%
Serine
14%
Signal Transduction
14%
Small Molecule
14%
STAT3
100%
Western Blot
14%
Wound Healing
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cell Viability
14%
Cytokine
14%
Drug Development
14%
Enzyme-Linked Immunosorbent Assay
14%
Fibronectin
14%
Laminin
14%
Liver Fibrosis
14%
Nuclear Factor
14%
Propidium Iodide
14%
Serine
14%
STAT3 Protein
100%
Western Blot
14%
Wound Healing
14%